JY
AMRI

Jeff Yass’s Albany Molecular Research Inc AMRI Stock Holding History

Jeff Yass’s Portfolio AMRI Stock Details AMRI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-63,600
Closed -$1.38M – 10230
2017
Q2 		$1.38M Buy
63,600
+52,800
+489% +$958K ﹤0.01% 4604
2017
Q1 		$152K Sell
10,800
-100
-0.9% -$1.64K ﹤0.01% 8189
2016
Q4 		$204K Sell
10,900
-1,200
-10% -$20.4K ﹤0.01% 8627
2016
Q3 		$200K Sell
12,100
-1,000
-8% -$14.8K ﹤0.01% 7587
2016
Q2 		$176K Buy
+13,100
New +$191K ﹤0.01% 7708
2015
Q3 		– Sell
-12,800
Closed -$259K – 10647
2015
Q2 		$259K Sell
12,800
-32,800
-72% -$633K ﹤0.01% 8820
2015
Q1 		$803K Sell
45,600
-10,900
-19% -$186K ﹤0.01% 6195
2014
Q4 		$920K Buy
56,500
+17,300
+44% +$317K ﹤0.01% 6039
2014
Q3 		$865K Buy
39,200
+15,500
+65% +$317K ﹤0.01% 6207
2014
Q2 		$477K Sell
23,700
-11,700
-33% -$198K ﹤0.01% 7563
2014
Q1 		$658K Buy
+35,400
New +$487K ﹤0.01% 6264
2013
Q4 		– Sell
-33,600
Closed -$433K – 9567
2013
Q3 		$433K Sell
33,600
-15,100
-31% -$186K ﹤0.01% 6655
2013
Q2 		$578K Buy
+48,700
New +$528K ﹤0.01% 5840

Other funds holding AMRI

AA
Ancora Advisors Cleveland, Ohio $5.19B AUM 23.19% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

Jeff Yass's AMRI Position: Q2 2015 in Review

Jeff Yass sold out of Albany Molecular Research Inc (AMRI) in Q2 2015, closing a stake of 48,841 shares — an estimated $943K sold.

Jeff Yass first reported a position in AMRI in Q4 2013 and held it in 2 quarters. The position peaked at $860K in Q1 2015. 131 funds tracked by Wall St. Rank hold AMRI as of Q2 2015.

  • Jeff Yass reported no remaining Albany Molecular Research Inc position as of Q2 2015 after selling out during the quarter.
  • Jeff Yass sold 48,841 Albany Molecular Research Inc shares in Q2 2015, an estimated $943K.
  • Jeff Yass first reported a position in Albany Molecular Research Inc in Q4 2013 and held it in 2 quarters.
  • Jeff Yass's Albany Molecular Research Inc position peaked at $860K in Q1 2015.
  • 131 funds tracked by Wall St. Rank held Albany Molecular Research Inc as of Q2 2015.

Based on Susquehanna International Group's 13F filing for Q2 2015, filed 14 Aug 2015.